Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Study Examines Impact of Unintended Pregnancy Among Active-Duty Soldiers
FRIDAY, July 26, 2024 -- Estimates of unintended pregnancy (UIP) among active-duty service women (ADSW) indicate a considerable impact on the ability to meet...
Gynecology-Related Internet Searches Up Following Release of Barbie Movie
FRIDAY, July 26, 2024 -- The closing line of the movie Barbie ("I'm here to see my gynecologist") may have spurred public interest in gynecology, according to...
Disparities Seen in Unintentional Firearm Mortality Across U.S. States
FRIDAY, July 26, 2024 -- There are considerable disparities in the rate of unintentional firearms mortality across the 50 U.S. states and District of...
FDA Approves Leqselvi (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata
MUMBAI, India and PRINCETON, N.J., July 26, 2024 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA...
Wildfires Are Creating Hazardous Air Conditions in Western North America
FRIDAY, July 26, 2024 -- Wildfires raging across the western parts of the United States and Canada are prompting air quality alerts and evacuation...
Prostate Cancer Outcomes Comparable for Transgender Women, Cisgender Men
FRIDAY, July 26, 2024 -- Most prostate cancer outcomes do not differ significantly between transgender women (TGW) and cisgender (CG) men, including prostate...
Boar's Head Recalls Liverwurst Tied to Listeria Outbreak
FRIDAY, July 26, 2024 -- Boar's Head announced Friday that it was recalling all of its liverwurst products because they could be tainted with dangerous...
Double Mastectomy May Offer No Survival Benefit to Women With Breast Cancer
FRIDAY, July 26, 2024 -- Women who are diagnosed with breast cancer in one breast, even in the early stages, sometimes opt for a double mastectomy, due to the...
Toxic Lead Found in Cinnamon Product, FDA Says
FRIDAY, July 26, 2024 -- An additional cinnamon product sold in the United States has been found to contain high levels of lead, health officials are...
Kids From Poorer Families Less Likely to Survive Cancer
FRIDAY, July 26, 2024 -- Children from poor families are less likely to survive cancer, particularly if they are not white, a new study reports. A childhood...
Certain Abbott Blood Sugar Monitors May Give Incorrect Readings
FRIDAY, July 26, 2024 -- Abbott has warned diabetes patients that some of its continuous blood sugar monitoring systems may need to be replaced because of...
FDA Approves Femlyv (norethindrone acetate and ethinyl estradiol) Orally Disintegrating Birth Control Pill
On July 22, 2024, the U.S. Food and Drug Administration (FDA) approved Femlyv (norethindrone acetate and ethinyl estradiol), the first orally disintegrating...
Merz Aesthetics Announces FDA Approval of Xeomin (incobotulinumtoxinA) as the First and Only U.S. Neurotoxin for the Simultaneous Treatment of Upper Facial Lines
RALEIGH, NC – July 23, 2024 -- Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the U.S. Food and Drug...
FDA Approves Epysqli (eculizumab-aagh), a Biosimilar to Soliris
INCHEON, South Korea, July 22, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved...
FDA Approves Zituvimet XR (sitagliptin and metformin hydrochloride) Extended-Release Tablets for Adults with Type 2 Diabetes
Ahmedabad, India, 19 July 2024 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received...
Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease
THOUSAND OAKS, Calif.--(BUSINESS WIRE) July 17, 2024 -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel...
Orexo Receives a Complete Response Letter Regarding the NDA for OX124, a High-Dose Naloxone Rescue Medication in Development for Opioid Overdose
Uppsala, Sweden – July 16, 2024 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces that the company has received a complete response...
Lexicon Pharmaceuticals Receives December 20, 2024 PDUFA Goal Date for Sotagliflozin Type 1 Diabetes NDA Resubmission
The Woodlands, Texas, July 16, 2024 - Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that the U.S. Food and Drug Administration (FDA) has...
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
DEER PARK, Ill., July 15, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative...
Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis
BOSTON--(BUSINESS WIRE)--Jul. 2, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has...
Presage Biosciences Announces First Patient Dosing of Pure Biologics' ROR1 Targeting Antibody For Treatment of Cancer
SEATTLE, July 25, 2024. Presage Biosciences, a biotechnology company that directly measures activity of oncology drugs within human tumors, announced the Phase...
Final Results from a Phase 2 Study of TPN-101 for the Treatment of C9orf72-Related Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia
SAN DIEGO, July 24, 2024. Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of...
Vivacelle Bio Initiates Phase 3 Trial for Lead Asset VBI-S to Treat Patients with Hypovolemia Due to Septic Shock
KANSAS CITY, Mo., July 23, 2024. Vivacelle Bio, a late-stage biopharma company developing life-saving treatments for shock and trauma, today announced the...
An Isolated Viral Load Test May Generate False Positive Results for People Using Long-Acting PrEP
July 23, 2024 -- A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA)...
Long-Acting Injectable Cabotegravir for HIV Prevention is Safe in Pregnancy
July 23, 2024 -- Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.